Skip to main navigation
Oral Delivery of Large Molecules
Oral Delivery of Large Molecules
Investor Relations
Home
About Us
Company Profile
Strategy
Management Team
Board of Directors
Technology
Oral Drug Delivery
Parathyroid Hormone
Supportive Publications
Hypoparathyroidism Market
Pipeline
Progress Summary
Hypoparathyroidism
Osteoporosis
Bone Healing
News and Events
News
Events
Investors
Share Information
Share Chart
Email Alerts
Press Releases
SEC Filings
Investor Calendar
Corporate Governance
Board of Directors
Management
Committee Composition
Investor Resources
Document Request
Email alerts
Investor FAQS
Investor Presentation
Contact Us
Oral Delivery of Large Molecules
Investor
Overview
Show all
Investor FAQs
When was Entera Bio founded?
Entera Bio was founded in 2010.
Where is the company headquartered?
Entera Bio is headquarterd at: Minrav Building - Fifth Floor
Kiryat Hadassah
Jerusalem 9112002, Israel
Which exchange do Entera Bio shares trade on?
Entera Bio shares trade on the NASDAQ Capital Market under the symbol "ENTX" for our ordinary shares and "ENTXW" for our warrants.
Does Entera Bio offer a direct stock purchase program?
Entera Bio does not offer a direct stock purchase program.
When does Entera Bio’s fiscal year end?
Entera Bio’s fiscal year ends on December 31.
How can I obtain Entera Bio SEC filings?
Entera Bio’s SEC filings, including its annual report, quarterly earnings releases and other investor materials are available under the “Investors” section of our corporate website. Additionally, all SEC filings can also be accessed directly from the SEC’s website at
www.sec.gov
.
Does Entera Bio plan to pay a cash dividend?
Entera Bio does not anticipate paying any cash dividends in the foreseeable future.
Who is Entera Bio’s transfer agent?
The transfer agent and registrar for Entera Bio is
American Stock Transfer & Trust
6201 15th Avenue
Brooklyn, NY 11219
United States
Phone: 718-921-8200
Fax: 718-236-2641
Website Address:
www.astfinancial.com
Email:
help@astfinancial.com
How do I contact Investor Relations?
InvestorRelations@Enterabio.com
Investor FAQs
Sidebar
Investor Presentation
Share Information
Share Chart
Press Releases
SEC Filings
Investor Calendar
Corporate Governance
Board of Directors
Management
Committee Composition
Investor Resources
Investor FAQs
Document Request
Email Alerts